Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL25323733

CC1CCCC(c2ccccc2)N1C(=O)C(N)=O.N

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 2/20 0.57
▸ WDR77 Q9BQA1 2/20 0.57
▸ ALDH1A1 P00352 2/20 0.48
▸ GLA P06280 1/20 0.48
▸ HPGD P15428 1/20 0.48
▸ RIPK1 Q13546 3/20 0.43
▸ CHRNB2 P17787 1/20 0.41
▸ CHRNB4 P30926 1/20 0.41
▸ CHRNA3 P32297 1/20 0.41
▸ CHRNA7 P36544 1/20 0.41
▸ CHRNA4 P43681 1/20 0.41
▸ KMT2A Q03164 2/20 0.40
▸ SIGMAR1 Q99720 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ ACHE P22303 1/20 0.38
▸ LMNA P02545 1/20 0.37
▸ GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL25323728 1.00 PRMT5 (0.57) PRMT5WDR77ALDH1A1GLAHPGD
SCHEMBL25324578 0.99 PRMT5 (0.58) PRMT5WDR77ALDH1A1GLAHPGD
SCHEMBL25324576 0.99 PRMT5 (0.58) PRMT5WDR77ALDH1A1GLAHPGD
SCHEMBL24367528 0.87 PRMT5 (0.57) PRMT5WDR77ALDH1A1GLAHPGD
SCHEMBL29477756 0.83 PRMT5 (0.54) PRMT5WDR77ALDH1A1GLAHPGD
SCHEMBL24366978 0.82 PRMT5 (0.56) PRMT5WDR77ALDH1A1GLAHPGD
SCHEMBL24366650 0.82 PRMT5 (0.56) PRMT5WDR77ALDH1A1GLAHPGD
SCHEMBL5516152 0.78 PRMT5 (0.52) PRMT5WDR77ALDH1A1GLAHPGD
SCHEMBL25321486 0.78 RIPK1 (0.43) PRMT5WDR77ALDH1A1RIPK1CHRNB2
SCHEMBL25321489 0.78 RIPK1 (0.43) PRMT5WDR77ALDH1A1RIPK1CHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4469455-A1 COMPOUNDS AND METHODS OF USE Tango Therapeutics, Inc. (US) 2024-12-04 — — EP disclosed
WO-2023146990-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
Send feedback